Levetiracetam Sun shortage — US supply status & alternatives

Levetiracetam Sun

—

🇦🇺 AUST R 201752 · Sun Pharma ANZ Pty Ltd

In supply · Australia

In supply · 🇦🇺 Australia · short in🇺🇸 US🇪🇸 ES

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

In supply

no shortage substitution needed

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Controlled substance
Active ingredient (INN)	Levetiracetam Sun
Therapeutic category	Auto-created by Agencia Española de Medicamentos — Problemas de Suministro scraper

Marketing-authorisation holders	Sun Pharma ANZ Pty Ltd, Sun Pharmaceutical Industries Europe B.V.

Registrations on file	2

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

Shortage status by regulator official notices

🇺🇸

United States

FDA MedWatch · 3d ago

High

🇪🇸

Spain

AEMPS · 14h ago

Medium

Verified timeline regulator events

🇪🇸 30 Apr 2025

medium reported

🇺🇸 26 Apr 2023

high reported

🇺🇸 26 Oct 2018

high reported

Sources official regulators

🇪🇸

AEMPS

verified 14h ago

verify ↗

🇺🇸

FDA MedWatch

verified 3d ago

verify ↗

🇺🇸

ANSM Ruptures

verified 1mo ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders2 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
Levetiracetam SUN levetiracetam	500mg	—	🇦🇺 AU	Sun Pharma ANZ Pty Ltd	Active
Levetiracetam Sun	—	—	🌐 EU	Sun Pharmaceutical Industries Europe B.V.	Active

Mederti Drug Report

Generated 5 July 2026 · Australia market · 3 regulatory sources

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.